[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"skill:01M75KMWATFQRKXEB0X5T7REZS":3,"skill-same:01M75KMWATFQRKXEB0X5T7REZS":46},{"skillNo":4,"name":5,"nameZh":6,"description":7,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":16,"categories":17,"keywords":18,"publishedAt":19,"linkOnly":20,"markdownContent":21,"markdownBody":22,"frontMatter":23,"refName":24,"commitSha":25,"skillDirectory":26,"forksCount":27,"repositoryHtmlUrl":28,"repositoryHomepageUrl":6,"ownerHtmlUrl":29,"ownerBlogUrl":6,"ownerDescription":30,"updatedAt":31,"install":32,"resources":45},"01M75KMWATFQRKXEB0X5T7REZS","preregistration",null,"Use when preregistering a study design (hypothesis, methods, analysis plan) before data collection on OSF Registries or AsPredicted, applying for ClinicalTrials.gov registration for interventional trials, or submitting a Registered Report.","pradyumnasagar\u002Fopen-research-skills","pradyumnasagar","https:\u002F\u002Favatars.githubusercontent.com\u002Fu\u002F10559871?v=4","01M75K78MYCCVKRTYGT8KKC380","Pradyumna Jayaram","01M75K78NTNE41F2PE1XBVFHAS",8,"MIT","https:\u002F\u002Fgithub.com\u002Fpradyumnasagar\u002Fopen-research-skills\u002Fblob\u002Fmain\u002Fskills\u002Fopen-science\u002Fpreregistration\u002FSKILL.md",[],[],"2026-11-12 13:55:43",false,"---\n\nname: preregistration\ndescription: \"Use when preregistering a study design (hypothesis, methods, analysis plan) before data collection on OSF Registries or AsPredicted, applying for ClinicalTrials.gov registration for interventional trials, or submitting a Registered Report.\"\nlicense: MIT\n---\n\u003C!-- metadata:\n  category: open-science\n  oversight: medium\n  version: 1.0.0\n  author: Pradyumna Jayaram\n  tags: [open-science, research]\n  difficulty: intermediate\n-->\n\n# Preregistration\n\n## Hard rules\n\n1. **No fabricated citations.** Every cited work must resolve to a verifiable\n2. **No claim without provenance.** Every quantitative or factual claim\n3. **No silent failure.** Every script invocation, API call, or tool use must declare its exit status and what to do on non-zero. A skill that silently swallows errors is a violation.\n\n## When to use\n\n- **Confirming a study design** before data collection starts — to commit to analysis.\n- Responding to reviewers or funder concerns about **p-hacking \u002F analytic flexibility**.\n- Required **ClinicalTrials.gov registration** for any interventional trial with a US site, NIH-funded, or FDA-regulated.\n- Submitting a **Registered Report** (peer review of the protocol before results).\n- Applying for a grant that asks for a **preregistration plan**.\n- Planning a **replication study** where the design must match the original.\n\n## When NOT to use\n\n- For **preprints** (posting a completed manuscript) — see `ors-open-science-preprints`.\n- For **data deposits** without a study plan — see `ors-open-science-fair-data`.\n- For **code release** (no hypothesis) — see `ors-open-science-code-release`.\n- For exploratory \u002F pilot \u002F feasibility work that is intended to generate hypotheses. Preregistration is for **confirmatory** research.\n- After data are already collected — preregistration is a pre-data commitment. You cannot preregister after the fact.\n- For purely observational \u002F database \u002F secondary-data analyses — these often use **analytic pre-registration** (specifying the analysis plan, not the data collection) on OSF.\n\n## Prerequisites\n\n- A **complete study protocol** (hypothesis, primary outcome, sample size, analysis plan).\n- ORCID iD for all authors (required for OSF and AsPredicted).\n- IRB\u002FIACUC approval number (or proof of exemption) — most registries ask for it.\n- For ClinicalTrials.gov: a Unique Trial Identifier (NCT number, if an amendment) or a sponsor-designated protocol.\n\n## Core workflow\n\n1. **Write the study protocol and analysis plan.** Use a template (see \"Document patterns\" below). Be specific: sample size N, primary outcome variable, primary analysis model, alpha, power, correction for multiple comparisons.\n2. **Choose the platform.** Use the decision tree:\n   - **Basic**: AsPredicted — simplest (one page, 10 questions).\n   - **Standard**: OSF Registries — most comprehensive, searchable, indexed in Crossref.\n   - **Regulated**: ClinicalTrials.gov — required by law for US interventional trials.\n   - **Publishing**: Registered Report format via a participating journal.\n3. **Upload to the platform.** Fill in the structured fields; attach the protocol as a PDF.\n4. **Timestamp.** The platform mints a DOI and date stamps the record. This is your proof of priority.\n5. **Collect the data.** Do **not** look at the primary outcome until data collection is complete. No peeking (or disclose that you peeked).\n6. **Run the analysis as specified.** If the analysis must change, disclose the change and explain why. Post-hoc changes are allowed but must be disclosed in the paper.\n7. **Link the preregistration to the paper.** Include the DOI in the final manuscript; cite the preregistration in the methods. Check the box in the journal submission system.\n8. **Update the record** for any changes (protocol amendments, sample-size re-estimation, analytic modifications).\n\n## Document patterns\n\n### Pattern 1: OSF vs AsPredicted vs ClinicalTrials.gov decision tree\n\n```\nIs this a US-regulated interventional clinical trial?\n├── YES → ClinicalTrials.gov (required by law)\n│         • Interventional (drug, device, gene therapy, etc.)\n│         • US site OR NIH-funded OR FDA-regulated\n│         • Must register BEFORE first patient enrolled\n│         • Required fields: NCT number, recruitment status,\n│           primary\u002Fsecondary outcomes, analysis plan\n└── NO  → Is this for a Registered Report (journal publication)?\n         ├── YES → Use the Registered Report format from the target journal\n         │        (e.g., Cortex, Open Science Framework, BMJ Open Science)\n         │        • Journal sends protocol out for peer review\n         │        • In-principle acceptance conditional on methods\n         │        • Results paper gets fast-track if methods are sound\n         └── NO  → Does the field expect a one-page confirmation?\n                  ├── YES → AsPredicted (simplest, 10 questions)\n                  │       • Common in psychology, social sciences, behavioral bio\n                  │       • Lightweight, fast (~15 min to complete)\n                  │       • No DOI (but has a unique URL and timestamp)\n                  └── NO  → OSF Registries (full-featured)\n                        • DOI ( searchable in Crossref)\n                        • 50+ fields, all searchable\n                        • Templates for different designs (RCT, survey, etc.)\n                        • The default for biology, neuroscience, most fields\n```\n\n### Pattern 2: The minimum preregistration fields (any platform)\n\nEvery preregistration must include:\n\n1. **Hypothesis** (what you are testing)\n2. **Primary outcome** (exactly what you will measure)\n3. **Sample size** (N, or stopping rule)\n4. **Inclusion\u002Fexclusion criteria** (who is in the study)\n5. **Analysis plan** (the statistical model)\n\nOptional but recommended:\n\n- **Secondary outcomes** (exploratory outcomes)\n- **Power calculation** (alpha, power, effect-size assumption)\n- **Correction for multiple comparisons** (correction method: Bonferroni, FDR, etc.)\n- **Exclusion criteria** (how you handle missing data, outliers)\n- **Data exclusions** (any QC criteria decided before seeing the data)\n- **Analysis software** (R, Python, JASP, etc.)\n\n### Pattern 3: OSF Registries preregistration template (abbreviated)\n\nMost OSF fields map to this skeleton:\n\n```markdown\n# Title\n[Hypothesis in one sentence.]\n\n# Hypothesis\n[State the directional hypothesis: \"We predict that X will increase Y...\"]\n\n# Primary outcome\n[Name the variable; how it will be measured; units.]\n\n# Secondary outcomes\n[Optional: list up to 3 secondary exploratory outcomes.]\n\n# Inclusion criteria\n- Age range: [...]\n- Population: [...]\n- Other: [...]\n\n# Exclusion criteria\n- [...]\n# Sample size\n- Target N: [...]\n- Power calculation: 80% power to detect d = [...] at α = 0.05\n\n# Analysis plan\n- Primary test: [e.g., linear mixed model with fixed effect of GROUP, random effect of SUBJECT]\n- Covariates: [age, sex, baseline score]\n- Alpha: 0.05 (two-tailed)\n\n# Exclusion rules\n- Any samples with \u003C 80% missing data will be excluded.\n- Outliers identified as > 3 SD from the mean will be flagged\n  and sensitivity analyses run with and without them.\n\n# Known deviations from the analysis plan\n[None to date \u002F Will be added if the protocol changes]\n\n# IRB approval\n- Protocol #[...] obtained from [Institutional Review Board name]\n- Approval date: [...]\n```\n\n### Pattern 4: AsPredicted (10 questions)\n\nAsPredicted simplifies to 10 questions:\n\n1. **What is the hypothesis?** (1 sentence)\n2. **What are the variables?**\n   - Independent variable(s):\n   - Dependent variable(s):\n3. **How many participants will you collect data from?** (N, or description of stopping rule)\n4. **When are you going to collect the data?** (dates or \"continuous\")\n5. **Is this a between- or within-subjects design?**\n6. **What analysis will you run to test the hypothesis?** (specify the test, e.g., \"t-test\", \"mixed-effects model\")\n7. **What does that analysis tell you?**\n8. **Any other analysis?** (list any secondary\u002F exploratory)\n9. **How can we contact you?** (email, ORCID)\n10. **Anything else?**\n\n### Pattern 5: ClinicalTrials.gov required fields\n\nFor US interventional trials, you must register:\n\n| Field | Description |\n|-------|-------------|\n| Unique Trial Identifier | NCT number (assigned on first save) |\n| Brief Title | ≤ 120 characters |\n| Official Title | Full title |\n| Study Type | Interventional |\n| Primary Outcome | Variable, measurement, time point |\n| Secondary Outcomes | Up to 10 |\n| Arms \u002F Interventions | Drug, device, procedure |\n| Eligibility | Inclusion\u002Fexclusion criteria |\n| Contact \u002F Sponsor | Name, phone, email |\n| Recruitment Status | Not yet recruiting \u002F Recruiting \u002F Completed \u002F etc. |\n| Study Start Date | Expected first enrollment |\n| Primary Completion Date | Expected last enrollment |\n| Completion Date | Expected final data collection |\n| Summary \u002F Description | ≤ 5000 characters |\n| Study Design | Allocation, masking, intervention model |\n| Masking | Who is blinded |\n| Intervention Model | Single group, parallel, crossover |\n| Number of Arms | 1, 2, 3+ |\n| Primary Purpose | Treatment, prevention, diagnostic, etc. |\n\nRegister **before** first patient enrolled. Updates required within 21 days of a change (recruitment status, primary outcome, sample size). Results must be posted within 12 months of the primary completion date.\n\n### Pattern 6: Registered Report formats\n\nRegistered Reports come in three \"formats\" (not versions, but stages):\n\n| Format | What is reviewed | What is guaranteed |\n|--------|-------------------|---------------------|\n| **Stage 1 (Protocol)** | The study design, hypothesis, methods, analysis | **In-principle acceptance** — if you run the study as specified, the results paper will be published (subject to minor review). |\n| **Stage 2 (Results)** | The results, with the protocol in the supplement | Peer review of the full paper. |\n| **Stage 3 (Registered Report)** | Protocol + Results in one submission | **Two-stage review** — protocol reviewed first, then results after data are collected. |\n\nMost journals offer **Stage 1** as the default. The workflow is:\n\n```\n1. Submit protocol (preregistration + analysis plan)\n2. Stage 1 peer review → in-principle acceptance (IPA) or revise and resubmit\n3. Collect data (do not look at results yet)\n4. Submit results paper with protocol in supplement\n5. Stage 2 peer review → publication OR major concerns (rare if IPA was given)\n```\n\nJournals that offer Registered Reports include:\n\n- **Cortex** (and other Center for Open Science partner journals)\n- **eLife** (exceptions apply)\n- **BMJ Open Science**\n- **F1000Research**\n- **Royal Society Open Science**\n- **Open Science Framework** journals\n\n## Common pitfalls\n\n| Pitfall | Why it fails | Fix |\n|---------|-------------|-----|\n| **Preregistering after data collection** | Not allowed; it's post-hoc, not pre-registration | Preregister BEFORE any data are touched. |\n| **Changing the analysis without disclosure** | Reviewers consider this undisclosed p-hacking | Any post-hoc changes go in the paper's limitations section with explanation. |\n| **AsPredicted for a clinical trial** | Not legally sufficient for FDA\u002FNIH registration | Use ClinicalTrials.gov for US interventional trials. |\n| **No sample-size justification** | Underpowered studies are the norm; reviewers ask | Include a power calculation (G*Power, R, or simulation). |\n| **Vague primary outcome** | \"We will measure gene expression\" is not specific | \"mRNA levels of gene X in peripheral blood monocytes, measured by qRT-PCR, normalized to GAPDH.\" |\n| **Not disclosing peeked data** | Reviewers assume you looked; they will ask in review | Write: \"One interim analysis was conducted at N = X; the study continued as planned because...\" |\n| **No IRB number** | Most journals require it; will be asked in review | Get IRB approval before preregistering. |\n| **Confusing preregistration with clinical trial registration** | Different requirements, different platforms | Clinical trials go to ClinicalTrials.gov. |\n| **Registered Report rejected at Stage 1** | The design or analysis was not sound | Revise per reviewer feedback; don't skip to a Stage 2 submission elsewhere without disclosing. |\n| **\"We did not preregister\" in a preregistered study** | The journal's check box will catch this | Either preregister or say \"preregistered, DOI: ...\" in the methods. |\n| **Including exploratory outcomes as primary** | This is p-hacking; reviewers see through it | Distinguish primary (confirmatory) from secondary (exploratory). The primary outcome gets the formal alpha; the rest are treated as hypothesis-generating. |\n| **Using an unregistered change as a limitation** | The fix is to disclose, not hide | Add a section \"Deviations from the preregistered protocol\" in the paper. |\n\n## Validation\n\nA preregistration is complete when:\n\n- [ ] The hypothesis is stated as a directional prediction (not a question).\n- [ ] The primary outcome is defined with exact variable name, measurement method, and time point.\n- [ ] The sample size is justified with a power calculation (or an explicit Bayesian stopping rule).\n- [ ] The analysis model is named (e.g., \"linear mixed model\", \"two-sample t-test\", \"Cox proportional hazards\").\n- [ ] The platform has minted a timestamp and (for OSF) a DOI.\n- [ ] All co-authors are listed and have approved the submission.\n- [ ] The IRB\u002FIACUC number is included.\n- [ ] The preregistration is linked in the final manuscript (DOI in the methods).\n- [ ] Any changes from the plan are disclosed in the final paper.\n\n## Open alternatives\n\n| Commercial \u002F restricted service | Open alternative | Trade-off |\n|----------------------------------|------------------|-----------|\n| ClinicalTrials.gov (required, free) | — | Required for US trials; no alternative. |\n| AsPredicted (free) | OSF Registries (also free) | OSF is more comprehensive; AsPredicted is simpler. |\n| PROSPERO (systematic reviews) | OSF Preregistration for systematic review protocols | PROSPERO is domain-specific for systematic reviews; OSF is general. |\n| REDCap (clinical data capture) | OpenClinica, Castor EDC | REDCap is free for academics; OpenClinica and Castor are also free for academics. |\n| SurveyMonkey (surveys) | Qualtrics (institutional license), Limesurvey (open-source) | Limesurvey is self-hosted, free; SurveyMonkey has a free tier. |\n| Dropbox Paper (collaborative writing) | HackMD \u002F HedgeDoc, Quarto, Manubot | Manubot is git-native, versioned. |\n\n## References\n\n- OSF Registries help: https:\u002F\u002Fosf.io\u002Fregistries\n- OSF Preregistration templates: https:\u002F\u002Fosf.io\u002Fprereg\n- AsPredicted: https:\u002F\u002Faspredicted.org\u002F\n- AsPredicted FAQ: https:\u002F\u002Faspredicted.org\u002Ffaq\n- ClinicalTrials.gov: https:\u002F\u002Fclinicaltrials.gov\u002F\n- ClinicalTrials.gov FAQs: https:\u002F\u002Fclinicaltrials.gov\u002Fctk\u002Fabout-trials\n- Registered Reports (cRedi): https:\u002F\u002Fcos.io\u002Frr\u002F\n- Registered Reports overview: https:\u002F\u002Fcos.io\u002Frr\u002F\n- SPIRIT 2013 statement: https:\u002F\u002Fwww.spirit-statement.org\u002F\n- CONSORT 2010: https:\u002F\u002Fwww.consort-statement.org\u002F\n- NIH Analytic Guide: supports preregistration for secondary analysis.\n- US OSTP 2023 memo: requires federally funded trials to register.\n- UK Reproducibility Network recommendations: https:\u002F\u002Fukrn.org\u002F\n- G*Power: https:\u002F\u002Fgpower.software.informer.com\u002F\n\n## Related skills\n\n- `ors-open-science-preprints` — to post the results after data collection.\n- `ors-open-science-fair-data` — to deposit the data after the paper is published.\n- `ors-open-science-code-release` — to release the code used in the analysis.\n- `ors-omics-statistics-` (multiple skills) — for statistical analysis methods.\n- `ors-bioinformatics-clinical-` (multiple) — for clinical data handling.\n\n## Changelog\n\n- 1.0.0 (2026-06-10): Initial adaptation by Pradyumna Jayaram. Synthesised OSF Registries help; AsPredicted FAQ; ClinicalTrials.gov fields; SPIRIT 2013; Registered Reports info (cRedi); NIH analytic guide; US OSTP memo. OSF vs AsPredicted vs ClinicalTrials decision tree; OSF template skeleton; AsPredicted 10 questions; Registered Report format comparison are original compositions.\n\n## Cross-references\n\nOther skills in this category:\n\n- code-release\n- fair-data\n- licensing\n- preprints\n","\u003C!-- metadata:\n  category: open-science\n  oversight: medium\n  version: 1.0.0\n  author: Pradyumna Jayaram\n  tags: [open-science, research]\n  difficulty: intermediate\n-->\n\n# Preregistration\n\n## Hard rules\n\n1. **No fabricated citations.** Every cited work must resolve to a verifiable\n2. **No claim without provenance.** Every quantitative or factual claim\n3. **No silent failure.** Every script invocation, API call, or tool use must declare its exit status and what to do on non-zero. A skill that silently swallows errors is a violation.\n\n## When to use\n\n- **Confirming a study design** before data collection starts — to commit to analysis.\n- Responding to reviewers or funder concerns about **p-hacking \u002F analytic flexibility**.\n- Required **ClinicalTrials.gov registration** for any interventional trial with a US site, NIH-funded, or FDA-regulated.\n- Submitting a **Registered Report** (peer review of the protocol before results).\n- Applying for a grant that asks for a **preregistration plan**.\n- Planning a **replication study** where the design must match the original.\n\n## When NOT to use\n\n- For **preprints** (posting a completed manuscript) — see `ors-open-science-preprints`.\n- For **data deposits** without a study plan — see `ors-open-science-fair-data`.\n- For **code release** (no hypothesis) — see `ors-open-science-code-release`.\n- For exploratory \u002F pilot \u002F feasibility work that is intended to generate hypotheses. Preregistration is for **confirmatory** research.\n- After data are already collected — preregistration is a pre-data commitment. You cannot preregister after the fact.\n- For purely observational \u002F database \u002F secondary-data analyses — these often use **analytic pre-registration** (specifying the analysis plan, not the data collection) on OSF.\n\n## Prerequisites\n\n- A **complete study protocol** (hypothesis, primary outcome, sample size, analysis plan).\n- ORCID iD for all authors (required for OSF and AsPredicted).\n- IRB\u002FIACUC approval number (or proof of exemption) — most registries ask for it.\n- For ClinicalTrials.gov: a Unique Trial Identifier (NCT number, if an amendment) or a sponsor-designated protocol.\n\n## Core workflow\n\n1. **Write the study protocol and analysis plan.** Use a template (see \"Document patterns\" below). Be specific: sample size N, primary outcome variable, primary analysis model, alpha, power, correction for multiple comparisons.\n2. **Choose the platform.** Use the decision tree:\n   - **Basic**: AsPredicted — simplest (one page, 10 questions).\n   - **Standard**: OSF Registries — most comprehensive, searchable, indexed in Crossref.\n   - **Regulated**: ClinicalTrials.gov — required by law for US interventional trials.\n   - **Publishing**: Registered Report format via a participating journal.\n3. **Upload to the platform.** Fill in the structured fields; attach the protocol as a PDF.\n4. **Timestamp.** The platform mints a DOI and date stamps the record. This is your proof of priority.\n5. **Collect the data.** Do **not** look at the primary outcome until data collection is complete. No peeking (or disclose that you peeked).\n6. **Run the analysis as specified.** If the analysis must change, disclose the change and explain why. Post-hoc changes are allowed but must be disclosed in the paper.\n7. **Link the preregistration to the paper.** Include the DOI in the final manuscript; cite the preregistration in the methods. Check the box in the journal submission system.\n8. **Update the record** for any changes (protocol amendments, sample-size re-estimation, analytic modifications).\n\n## Document patterns\n\n### Pattern 1: OSF vs AsPredicted vs ClinicalTrials.gov decision tree\n\n```\nIs this a US-regulated interventional clinical trial?\n├── YES → ClinicalTrials.gov (required by law)\n│         • Interventional (drug, device, gene therapy, etc.)\n│         • US site OR NIH-funded OR FDA-regulated\n│         • Must register BEFORE first patient enrolled\n│         • Required fields: NCT number, recruitment status,\n│           primary\u002Fsecondary outcomes, analysis plan\n└── NO  → Is this for a Registered Report (journal publication)?\n         ├── YES → Use the Registered Report format from the target journal\n         │        (e.g., Cortex, Open Science Framework, BMJ Open Science)\n         │        • Journal sends protocol out for peer review\n         │        • In-principle acceptance conditional on methods\n         │        • Results paper gets fast-track if methods are sound\n         └── NO  → Does the field expect a one-page confirmation?\n                  ├── YES → AsPredicted (simplest, 10 questions)\n                  │       • Common in psychology, social sciences, behavioral bio\n                  │       • Lightweight, fast (~15 min to complete)\n                  │       • No DOI (but has a unique URL and timestamp)\n                  └── NO  → OSF Registries (full-featured)\n                        • DOI ( searchable in Crossref)\n                        • 50+ fields, all searchable\n                        • Templates for different designs (RCT, survey, etc.)\n                        • The default for biology, neuroscience, most fields\n```\n\n### Pattern 2: The minimum preregistration fields (any platform)\n\nEvery preregistration must include:\n\n1. **Hypothesis** (what you are testing)\n2. **Primary outcome** (exactly what you will measure)\n3. **Sample size** (N, or stopping rule)\n4. **Inclusion\u002Fexclusion criteria** (who is in the study)\n5. **Analysis plan** (the statistical model)\n\nOptional but recommended:\n\n- **Secondary outcomes** (exploratory outcomes)\n- **Power calculation** (alpha, power, effect-size assumption)\n- **Correction for multiple comparisons** (correction method: Bonferroni, FDR, etc.)\n- **Exclusion criteria** (how you handle missing data, outliers)\n- **Data exclusions** (any QC criteria decided before seeing the data)\n- **Analysis software** (R, Python, JASP, etc.)\n\n### Pattern 3: OSF Registries preregistration template (abbreviated)\n\nMost OSF fields map to this skeleton:\n\n```markdown\n# Title\n[Hypothesis in one sentence.]\n\n# Hypothesis\n[State the directional hypothesis: \"We predict that X will increase Y...\"]\n\n# Primary outcome\n[Name the variable; how it will be measured; units.]\n\n# Secondary outcomes\n[Optional: list up to 3 secondary exploratory outcomes.]\n\n# Inclusion criteria\n- Age range: [...]\n- Population: [...]\n- Other: [...]\n\n# Exclusion criteria\n- [...]\n# Sample size\n- Target N: [...]\n- Power calculation: 80% power to detect d = [...] at α = 0.05\n\n# Analysis plan\n- Primary test: [e.g., linear mixed model with fixed effect of GROUP, random effect of SUBJECT]\n- Covariates: [age, sex, baseline score]\n- Alpha: 0.05 (two-tailed)\n\n# Exclusion rules\n- Any samples with \u003C 80% missing data will be excluded.\n- Outliers identified as > 3 SD from the mean will be flagged\n  and sensitivity analyses run with and without them.\n\n# Known deviations from the analysis plan\n[None to date \u002F Will be added if the protocol changes]\n\n# IRB approval\n- Protocol #[...] obtained from [Institutional Review Board name]\n- Approval date: [...]\n```\n\n### Pattern 4: AsPredicted (10 questions)\n\nAsPredicted simplifies to 10 questions:\n\n1. **What is the hypothesis?** (1 sentence)\n2. **What are the variables?**\n   - Independent variable(s):\n   - Dependent variable(s):\n3. **How many participants will you collect data from?** (N, or description of stopping rule)\n4. **When are you going to collect the data?** (dates or \"continuous\")\n5. **Is this a between- or within-subjects design?**\n6. **What analysis will you run to test the hypothesis?** (specify the test, e.g., \"t-test\", \"mixed-effects model\")\n7. **What does that analysis tell you?**\n8. **Any other analysis?** (list any secondary\u002F exploratory)\n9. **How can we contact you?** (email, ORCID)\n10. **Anything else?**\n\n### Pattern 5: ClinicalTrials.gov required fields\n\nFor US interventional trials, you must register:\n\n| Field | Description |\n|-------|-------------|\n| Unique Trial Identifier | NCT number (assigned on first save) |\n| Brief Title | ≤ 120 characters |\n| Official Title | Full title |\n| Study Type | Interventional |\n| Primary Outcome | Variable, measurement, time point |\n| Secondary Outcomes | Up to 10 |\n| Arms \u002F Interventions | Drug, device, procedure |\n| Eligibility | Inclusion\u002Fexclusion criteria |\n| Contact \u002F Sponsor | Name, phone, email |\n| Recruitment Status | Not yet recruiting \u002F Recruiting \u002F Completed \u002F etc. |\n| Study Start Date | Expected first enrollment |\n| Primary Completion Date | Expected last enrollment |\n| Completion Date | Expected final data collection |\n| Summary \u002F Description | ≤ 5000 characters |\n| Study Design | Allocation, masking, intervention model |\n| Masking | Who is blinded |\n| Intervention Model | Single group, parallel, crossover |\n| Number of Arms | 1, 2, 3+ |\n| Primary Purpose | Treatment, prevention, diagnostic, etc. |\n\nRegister **before** first patient enrolled. Updates required within 21 days of a change (recruitment status, primary outcome, sample size). Results must be posted within 12 months of the primary completion date.\n\n### Pattern 6: Registered Report formats\n\nRegistered Reports come in three \"formats\" (not versions, but stages):\n\n| Format | What is reviewed | What is guaranteed |\n|--------|-------------------|---------------------|\n| **Stage 1 (Protocol)** | The study design, hypothesis, methods, analysis | **In-principle acceptance** — if you run the study as specified, the results paper will be published (subject to minor review). |\n| **Stage 2 (Results)** | The results, with the protocol in the supplement | Peer review of the full paper. |\n| **Stage 3 (Registered Report)** | Protocol + Results in one submission | **Two-stage review** — protocol reviewed first, then results after data are collected. |\n\nMost journals offer **Stage 1** as the default. The workflow is:\n\n```\n1. Submit protocol (preregistration + analysis plan)\n2. Stage 1 peer review → in-principle acceptance (IPA) or revise and resubmit\n3. Collect data (do not look at results yet)\n4. Submit results paper with protocol in supplement\n5. Stage 2 peer review → publication OR major concerns (rare if IPA was given)\n```\n\nJournals that offer Registered Reports include:\n\n- **Cortex** (and other Center for Open Science partner journals)\n- **eLife** (exceptions apply)\n- **BMJ Open Science**\n- **F1000Research**\n- **Royal Society Open Science**\n- **Open Science Framework** journals\n\n## Common pitfalls\n\n| Pitfall | Why it fails | Fix |\n|---------|-------------|-----|\n| **Preregistering after data collection** | Not allowed; it's post-hoc, not pre-registration | Preregister BEFORE any data are touched. |\n| **Changing the analysis without disclosure** | Reviewers consider this undisclosed p-hacking | Any post-hoc changes go in the paper's limitations section with explanation. |\n| **AsPredicted for a clinical trial** | Not legally sufficient for FDA\u002FNIH registration | Use ClinicalTrials.gov for US interventional trials. |\n| **No sample-size justification** | Underpowered studies are the norm; reviewers ask | Include a power calculation (G*Power, R, or simulation). |\n| **Vague primary outcome** | \"We will measure gene expression\" is not specific | \"mRNA levels of gene X in peripheral blood monocytes, measured by qRT-PCR, normalized to GAPDH.\" |\n| **Not disclosing peeked data** | Reviewers assume you looked; they will ask in review | Write: \"One interim analysis was conducted at N = X; the study continued as planned because...\" |\n| **No IRB number** | Most journals require it; will be asked in review | Get IRB approval before preregistering. |\n| **Confusing preregistration with clinical trial registration** | Different requirements, different platforms | Clinical trials go to ClinicalTrials.gov. |\n| **Registered Report rejected at Stage 1** | The design or analysis was not sound | Revise per reviewer feedback; don't skip to a Stage 2 submission elsewhere without disclosing. |\n| **\"We did not preregister\" in a preregistered study** | The journal's check box will catch this | Either preregister or say \"preregistered, DOI: ...\" in the methods. |\n| **Including exploratory outcomes as primary** | This is p-hacking; reviewers see through it | Distinguish primary (confirmatory) from secondary (exploratory). The primary outcome gets the formal alpha; the rest are treated as hypothesis-generating. |\n| **Using an unregistered change as a limitation** | The fix is to disclose, not hide | Add a section \"Deviations from the preregistered protocol\" in the paper. |\n\n## Validation\n\nA preregistration is complete when:\n\n- [ ] The hypothesis is stated as a directional prediction (not a question).\n- [ ] The primary outcome is defined with exact variable name, measurement method, and time point.\n- [ ] The sample size is justified with a power calculation (or an explicit Bayesian stopping rule).\n- [ ] The analysis model is named (e.g., \"linear mixed model\", \"two-sample t-test\", \"Cox proportional hazards\").\n- [ ] The platform has minted a timestamp and (for OSF) a DOI.\n- [ ] All co-authors are listed and have approved the submission.\n- [ ] The IRB\u002FIACUC number is included.\n- [ ] The preregistration is linked in the final manuscript (DOI in the methods).\n- [ ] Any changes from the plan are disclosed in the final paper.\n\n## Open alternatives\n\n| Commercial \u002F restricted service | Open alternative | Trade-off |\n|----------------------------------|------------------|-----------|\n| ClinicalTrials.gov (required, free) | — | Required for US trials; no alternative. |\n| AsPredicted (free) | OSF Registries (also free) | OSF is more comprehensive; AsPredicted is simpler. |\n| PROSPERO (systematic reviews) | OSF Preregistration for systematic review protocols | PROSPERO is domain-specific for systematic reviews; OSF is general. |\n| REDCap (clinical data capture) | OpenClinica, Castor EDC | REDCap is free for academics; OpenClinica and Castor are also free for academics. |\n| SurveyMonkey (surveys) | Qualtrics (institutional license), Limesurvey (open-source) | Limesurvey is self-hosted, free; SurveyMonkey has a free tier. |\n| Dropbox Paper (collaborative writing) | HackMD \u002F HedgeDoc, Quarto, Manubot | Manubot is git-native, versioned. |\n\n## References\n\n- OSF Registries help: https:\u002F\u002Fosf.io\u002Fregistries\n- OSF Preregistration templates: https:\u002F\u002Fosf.io\u002Fprereg\n- AsPredicted: https:\u002F\u002Faspredicted.org\u002F\n- AsPredicted FAQ: https:\u002F\u002Faspredicted.org\u002Ffaq\n- ClinicalTrials.gov: https:\u002F\u002Fclinicaltrials.gov\u002F\n- ClinicalTrials.gov FAQs: https:\u002F\u002Fclinicaltrials.gov\u002Fctk\u002Fabout-trials\n- Registered Reports (cRedi): https:\u002F\u002Fcos.io\u002Frr\u002F\n- Registered Reports overview: https:\u002F\u002Fcos.io\u002Frr\u002F\n- SPIRIT 2013 statement: https:\u002F\u002Fwww.spirit-statement.org\u002F\n- CONSORT 2010: https:\u002F\u002Fwww.consort-statement.org\u002F\n- NIH Analytic Guide: supports preregistration for secondary analysis.\n- US OSTP 2023 memo: requires federally funded trials to register.\n- UK Reproducibility Network recommendations: https:\u002F\u002Fukrn.org\u002F\n- G*Power: https:\u002F\u002Fgpower.software.informer.com\u002F\n\n## Related skills\n\n- `ors-open-science-preprints` — to post the results after data collection.\n- `ors-open-science-fair-data` — to deposit the data after the paper is published.\n- `ors-open-science-code-release` — to release the code used in the analysis.\n- `ors-omics-statistics-` (multiple skills) — for statistical analysis methods.\n- `ors-bioinformatics-clinical-` (multiple) — for clinical data handling.\n\n## Changelog\n\n- 1.0.0 (2026-06-10): Initial adaptation by Pradyumna Jayaram. Synthesised OSF Registries help; AsPredicted FAQ; ClinicalTrials.gov fields; SPIRIT 2013; Registered Reports info (cRedi); NIH analytic guide; US OSTP memo. OSF vs AsPredicted vs ClinicalTrials decision tree; OSF template skeleton; AsPredicted 10 questions; Registered Report format comparison are original compositions.\n\n## Cross-references\n\nOther skills in this category:\n\n- code-release\n- fair-data\n- licensing\n- preprints\n",{"name":5,"license":15,"description":7},"main","9c0b41e2036cc5588c699f06e658ea6dc3b9685d","skills\u002Fopen-science\u002Fpreregistration",2,"https:\u002F\u002Fgithub.com\u002Fpradyumnasagar\u002Fopen-research-skills","https:\u002F\u002Fgithub.com\u002Fpradyumnasagar","PhD Scholar,\r\nManipal School Of Life Sciences, Manipal\r\n #OpenSourceDeveloper #LifeSciences #ComputationalBiology","2026-10-30 01:30:52",{"source":8,"skillName":5,"commands":33,"prompt":43,"zipAvailable":44},[34,37,40],{"tool":35,"command":36},"npx","npx skills add pradyumnasagar\u002Fopen-research-skills --skill preregistration",{"tool":38,"command":39},"bunx","bunx skills add pradyumnasagar\u002Fopen-research-skills --skill preregistration",{"tool":41,"command":42},"pnpm","pnpm dlx skills add pradyumnasagar\u002Fopen-research-skills --skill preregistration","安装技能，技能地址：https:\u002F\u002Fgithub.com\u002Fpradyumnasagar\u002Fopen-research-skills\u002Fblob\u002Fmain\u002Fskills\u002Fopen-science\u002Fpreregistration\u002FSKILL.md",true,[],[47,54,60,67,74,81],{"skillNo":48,"name":49,"nameZh":6,"description":50,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":51,"categories":52,"keywords":53,"publishedAt":19},"01M75KTS5K9QNX8FQBTJW2GQSH","good-skill","A well-formed test fixture for the validation script.","https:\u002F\u002Fgithub.com\u002Fpradyumnasagar\u002Fopen-research-skills\u002Fblob\u002Fmain\u002Ftests\u002Ffixtures\u002Fgood-skill\u002FSKILL.md",[],[],{"skillNo":55,"name":56,"nameZh":6,"description":6,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":57,"categories":58,"keywords":59,"publishedAt":19},"01M75KTR7FAT0MMMED2EGC9WZZ","BadSkill","https:\u002F\u002Fgithub.com\u002Fpradyumnasagar\u002Fopen-research-skills\u002Fblob\u002Fmain\u002Ftests\u002Ffixtures\u002Fbad-skill\u002FSKILL.md",[],[],{"skillNo":61,"name":62,"nameZh":6,"description":63,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":64,"categories":65,"keywords":66,"publishedAt":19},"01M75KTN949EDF77GJDS8H6VR8","my-new-skill","One sentence (max 200 chars) — what the skill does and when to use it.","https:\u002F\u002Fgithub.com\u002Fpradyumnasagar\u002Fopen-research-skills\u002Fblob\u002Fmain\u002Ftemplate\u002FSKILL.md",[],[],{"skillNo":68,"name":69,"nameZh":6,"description":70,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":71,"categories":72,"keywords":73,"publishedAt":19},"01M75KTHTFS121SSF1Q5X2FXDA","thesis-structure","Use when planning or checking the architecture of a PhD \u002F MPhil thesis in the life sciences or bioinformatics — monograph vs article-based, chapter sequence, IMRaD-based chapters, abstract-to-conclusion flow, and the examiner expectations that the structure must meet.","https:\u002F\u002Fgithub.com\u002Fpradyumnasagar\u002Fopen-research-skills\u002Fblob\u002Fmain\u002Fskills\u002Fthesis-writing\u002Fthesis-structure\u002FSKILL.md",[],[],{"skillNo":75,"name":76,"nameZh":6,"description":77,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":78,"categories":79,"keywords":80,"publishedAt":19},"01M75KTE3WKW46FXFHQ579H8YP","thesis-methods-reproducibility","Use when writing or checking the Methods, figures, data, and code of a bioinformatics \u002F microbiology \u002F life-science PhD thesis — the FAIR data, versioned code, report-generation, figure-and-table discipline, and the reproducibility expectations that examiners probe at viva.","https:\u002F\u002Fgithub.com\u002Fpradyumnasagar\u002Fopen-research-skills\u002Fblob\u002Fmain\u002Fskills\u002Fthesis-writing\u002Fthesis-methods-reproducibility\u002FSKILL.md",[],[],{"skillNo":82,"name":83,"nameZh":6,"description":84,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":85,"categories":86,"keywords":87,"publishedAt":19},"01M75KTA033ZQCJY3DC8P5VQET","thesis-defense-viva","Use when preparing for the viva voce \u002F oral thesis defense — building the examiner's question set, rehearsing the presentation, and the pre-defense polish (slides, summary, the 'what if I'm stuck' responses) for a life-science or bioinformatics PhD.","https:\u002F\u002Fgithub.com\u002Fpradyumnasagar\u002Fopen-research-skills\u002Fblob\u002Fmain\u002Fskills\u002Fthesis-writing\u002Fthesis-defense-viva\u002FSKILL.md",[],[]]